| Year |
Citation |
Score |
| 2022 |
Giovannoni G, Popescu V, Wuerfel J, Hellwig K, Iacobeus E, Jensen MB, García-Domínguez JM, Sousa L, De Rossi N, Hupperts R, Fenu G, Bodini B, Kuusisto HM, Stankoff B, Lycke J, ... Airas L, et al. Smouldering multiple sclerosis: the 'real MS'. Therapeutic Advances in Neurological Disorders. 15: 17562864211066751. PMID 35096143 DOI: 10.1177/17562864211066751 |
0.311 |
|
| 2021 |
Elo P, Li XG, Liljenbäck H, Gardberg M, Moisio O, Miner M, Virta J, Saraste A, Srinivasarao M, Pugh M, Low PS, Knuuti J, Jalkanen S, Airas L, Lu YJ, et al. Efficacy and tolerability of folate-aminopterin therapy in a rat focal model of multiple sclerosis. Journal of Neuroinflammation. 18: 30. PMID 33472663 DOI: 10.1186/s12974-021-02073-7 |
0.505 |
|
| 2020 |
Bezukladova S, Tuisku J, Matilainen M, Vuorimaa A, Nylund M, Smith S, Sucksdorff M, Mohammadian M, Saunavaara V, Laaksonen S, Rokka J, Rinne JO, Rissanen E, Airas L. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging. Neurology(R) Neuroimmunology & Neuroinflammation. 7. PMID 32123046 DOI: 10.1212/Nxi.0000000000000691 |
0.38 |
|
| 2020 |
Airas L, Nylund M, Mannonen I, Matilainen M, Sucksdorff M, Rissanen E. Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland. Multiple Sclerosis and Related Disorders. 40: 101980. PMID 32066031 DOI: 10.1016/J.Msard.2020.101980 |
0.449 |
|
| 2019 |
Elo P, Li XG, Liljenbäck H, Helin S, Teuho J, Koskensalo K, Saunavaara V, Marjamäki P, Oikonen V, Virta J, Chen Q, Low PS, Knuuti J, Jalkanen S, Airas L, et al. Folate receptor-targeted positron emission tomography of experimental autoimmune encephalomyelitis in rats. Journal of Neuroinflammation. 16: 252. PMID 31796042 DOI: 10.1186/S12974-019-1612-3 |
0.47 |
|
| 2019 |
Kaasinen V, Joutsa J, Rissanen E, Airas L, Soilu-Hänninen M, Noponen T. Progressive dopaminergic defect in a patient with primary progressive multiple sclerosis. Multiple Sclerosis and Related Disorders. 36: 101385. PMID 31518774 DOI: 10.1016/J.Msard.2019.101385 |
0.369 |
|
| 2019 |
Sucksdorff M, Tuisku J, Matilainen M, Vuorimaa A, Smith S, Keitilä J, Rokka J, Parkkola R, Nylund M, Rinne J, Rissanen E, Airas L. Natalizumab treatment reduces microglial activation in the white matter of the MS brain. Neurology(R) Neuroimmunology & Neuroinflammation. 6: e574. PMID 31355310 DOI: 10.1212/Nxi.0000000000000574 |
0.39 |
|
| 2019 |
Vainio SK, Dickens AM, Tuisku J, Eskola O, Solin O, Löyttyniemi E, Anthony DC, Rinne JO, Airas L, Haaparanta-Solin M. Cessation of anti-VLA-4 therapy in a focal rat model of multiple sclerosis causes an increase in neuroinflammation. Ejnmmi Research. 9: 38. PMID 31073768 DOI: 10.1186/S13550-019-0508-7 |
0.315 |
|
| 2019 |
Wolinsky J, Brochet B, Hartung H, Naismith R, Airas L, Coutant K, Koendgen H, Manfrini M, Mehta L, Prajapati K, Kappos L. Sustained reduction in confirmed disability progression after 6.5 study-years of ocrelizumab treatment in patients with primary progressive multiple sclerosis Journal of the Neurological Sciences. 405: 31. DOI: 10.1016/J.Jns.2019.10.269 |
0.354 |
|
| 2018 |
Högel H, Rissanen E, Barro C, Matilainen M, Nylund M, Kuhle J, Airas L. Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity. Multiple Sclerosis (Houndmills, Basingstoke, England). 1352458518819380. PMID 30570436 DOI: 10.1177/1352458518819380 |
0.319 |
|
| 2018 |
Ponath G, Lincoln MR, Levine-Ritterman M, Park C, Dahlawi S, Mubarak M, Sumida T, Airas L, Zhang S, Isitan C, Nguyen TD, Raine CS, Hafler DA, Pitt D. Enhanced astrocyte responses are driven by a genetic risk allele associated with multiple sclerosis. Nature Communications. 9: 5337. PMID 30559390 DOI: 10.1038/S41467-018-07785-8 |
0.374 |
|
| 2018 |
Högel H, Rissanen E, Vuorimaa A, Airas L. Positron emission tomography imaging in evaluation of MS pathology in vivo. Multiple Sclerosis (Houndmills, Basingstoke, England). 24: 1399-1412. PMID 30091657 DOI: 10.1177/1352458518791680 |
0.401 |
|
| 2018 |
Elo P, Tadayon S, Liljenbäck H, Teuho J, Käkelä M, Koskensalo K, Saunavaara V, Virta J, Veres TZ, Kiviniemi A, Saraste A, Marjamäki P, Airas L, Jalkanen S, Roivainen A. Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis. Journal of Neuroinflammation. 15: 128. PMID 29716612 DOI: 10.1186/S12974-018-1152-2 |
0.55 |
|
| 2018 |
Airas L, Nylund M, Rissanen E. Evaluation of Microglial Activation in Multiple Sclerosis Patients Using Positron Emission Tomography. Frontiers in Neurology. 9: 181. PMID 29632509 DOI: 10.3389/Fneur.2018.00181 |
0.44 |
|
| 2018 |
Saarela M, Senthil K, Jones J, Tienari PJ, Soilu-Hänninen M, Airas L, Coles A, Saarinen JT. Hemophagocytic lymphohistiocytosis in 2 patients with multiple sclerosis treated with alemtuzumab. Neurology. PMID 29602914 DOI: 10.1212/Wnl.0000000000005420 |
0.346 |
|
| 2018 |
Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R, Rokka J, Gerhard A, Hinz R, Talbot PS, Rinne JO, Airas L. Microglial activation, white matter tract damage, and disability in MS. Neurology(R) Neuroimmunology & Neuroinflammation. 5: e443. PMID 29520366 DOI: 10.1212/Nxi.0000000000000443 |
0.383 |
|
| 2018 |
Saraste M, Atula S, Hedman K, Hurme S, Jalkanen A, Sneck M, Surcel HM, Maghzi AH, Airas L. Humoral response to John Cunningham virus during pregnancy in multiple sclerosis. Multiple Sclerosis and Related Disorders. 21: 11-18. PMID 29454151 DOI: 10.1016/J.Msard.2018.02.008 |
0.355 |
|
| 2018 |
Rissanen E, Remes K, Airas L. Severe neutropenia after rituximab-treatment of multiple sclerosis. Multiple Sclerosis and Related Disorders. 20: 3-5. PMID 29253744 DOI: 10.1016/J.Msard.2017.12.005 |
0.366 |
|
| 2017 |
Sucksdorff M, Rissanen E, Tuisku J, Nuutinen S, Paavilainen T, Rokka J, Rinne J, Airas L. Evaluation of the effect of fingolimod treatment on microglial activation using serial PET imaging in multiple sclerosis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28336784 DOI: 10.2967/Jnumed.116.183020 |
0.411 |
|
| 2017 |
Airas L, Rissanen E, Rinne J. Imaging of microglial activation in MS using PET: Research use and potential future clinical application. Multiple Sclerosis (Houndmills, Basingstoke, England). 23: 496-504. PMID 27760860 DOI: 10.1177/1352458516674568 |
0.394 |
|
| 2016 |
Tarkkonen A, Rissanen E, Tuokkola T, Airas L. Utilization of PET imaging in differential diagnostics between a tumefactive multiple sclerosis lesion and low-grade glioma. Multiple Sclerosis and Related Disorders. 9: 147-9. PMID 27645363 DOI: 10.1016/J.Msard.2016.07.016 |
0.354 |
|
| 2016 |
Gilmore W, Airas L. Successive pregnancies in multiple sclerosis. Neurology. 87: 1316-7. PMID 27466469 DOI: 10.1212/Wnl.0000000000003039 |
0.388 |
|
| 2016 |
Hovi A, Airas L. Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 11: 611-612. PMID 27388874 DOI: 10.1007/S11481-016-9697-2 |
0.322 |
|
| 2016 |
Airas L. Hormonal and gender-related immune changes in multiple sclerosis. Acta Neurologica Scandinavica. 132: 62-70. PMID 26046561 DOI: 10.1111/Ane.12433 |
0.397 |
|
| 2016 |
Airas L. Neuroinflammation in multiple sclerosis European Neuropsychopharmacology. 26: S149. DOI: 10.1016/S0924-977X(16)30958-0 |
0.391 |
|
| 2015 |
Airas L, Rissanen E, Rinne JO. Imaging neuroinflammation in multiple sclerosis using TSPO-PET. Clinical and Translational Imaging. 3: 461-473. PMID 27331049 DOI: 10.1007/S40336-015-0147-6 |
0.387 |
|
| 2015 |
Kolasa M, Hagman S, Verkkoniemi-Ahola A, Airas L, Koivisto K, Elovaara I. Anti-JC virus seroprevalence in a Finnish MS cohort. Acta Neurologica Scandinavica. 133: 391-7. PMID 26347001 DOI: 10.1111/Ane.12475 |
0.348 |
|
| 2015 |
Basnyat P, Hagman S, Kolasa M, Koivisto K, Verkkoniemi-Ahola A, Airas L, Elovaara I. Association between soluble L-selectin and anti-JCV antibodies in natalizumab-treated relapsing-remitting MS patients. Multiple Sclerosis and Related Disorders. 4: 334-8. PMID 26195052 DOI: 10.1016/J.Jns.2015.08.131 |
0.402 |
|
| 2015 |
Airas L, Säpyskä N, Broberg E. No evidence of human herpesvirus DNA in the CSF of multiple sclerosis patients. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 36: 1053-4. PMID 25613860 DOI: 10.1007/S10072-015-2081-9 |
0.302 |
|
| 2015 |
Airas L, Dickens AM, Elo P, Marjamäki P, Johansson J, Eskola O, Jones PA, Trigg W, Solin O, Haaparanta-Solin M, Anthony DC, Rinne J. In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 305-10. PMID 25572093 DOI: 10.2967/Jnumed.114.149955 |
0.405 |
|
| 2015 |
Jalkanen A, Kauko T, Koskinen JO, Waris ME, Airas L. Elevated concentration of C-reactive protein is associated with pregnancy-related co-morbidities but not with relapse activity in multiple sclerosis. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 36: 441-7. PMID 25308726 DOI: 10.1007/S10072-014-1980-5 |
0.405 |
|
| 2015 |
Basnyat P, Natarajan R, Vistbakka J, Lehtikangas M, Airas L, Matinlauri I, Elovaara I, Hagman S. Elevated levels of soluble CD26 and CD30 in multiple sclerosis Clinical and Experimental Neuroimmunology. 6: 419-425. DOI: 10.1111/Cen3.12253 |
0.474 |
|
| 2015 |
Airas L, Rissanen E, Tuisku J, Gardberg M, Rinne J. Microglial activation correlates with disease progression in multiple sclerosis Journal of the Neurological Sciences. 357: e17-e18. DOI: 10.1016/J.Jns.2015.08.127 |
0.347 |
|
| 2014 |
Jalkanen A, Kauko T, Turpeinen U, Hämäläinen E, Airas L. Multiple sclerosis and vitamin D during pregnancy and lactation. Acta Neurologica Scandinavica. 131: 64-7. PMID 25216350 DOI: 10.1111/Ane.12306 |
0.338 |
|
| 2014 |
Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, Airas L. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 939-44. PMID 24711650 DOI: 10.2967/Jnumed.113.131698 |
0.356 |
|
| 2014 |
Jalkanen A, Kauko T, Koskinen JO, Waris ME, Airas L. Labour-associated increase in C-reactive protein concentration is not predictive of postpartum relapse activity among mothers with multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 20: 1790-1. PMID 24696054 DOI: 10.1177/1352458514528764 |
0.306 |
|
| 2014 |
Oreja-Guevara C, Wiendl H, Kieseier BC, Airas L. Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner. Therapeutic Advances in Neurological Disorders. 7: 137-49. PMID 24587828 DOI: 10.1177/1756285613501575 |
0.36 |
|
| 2014 |
De Stefano N, Airas L, Grigoriadis N, Mattle HP, O'Riordan J, Oreja-Guevara C, Sellebjerg F, Stankoff B, Walczak A, Wiendl H, Kieseier BC. Clinical relevance of brain volume measures in multiple sclerosis. Cns Drugs. 28: 147-56. PMID 24446248 DOI: 10.1007/S40263-014-0140-Z |
0.339 |
|
| 2014 |
Airas L, Rissanen E, Gardberg M, Sucksdorff M, Tuisku J, Rinne J. Brain positron emission tomography scanning can be used to image pathological determinants of progressive multiple sclerosis Journal of Neuroimmunology. 275: 182-183. DOI: 10.1016/J.Jneuroim.2014.08.490 |
0.325 |
|
| 2014 |
Søndergaard HB, Airas L, Mendel-hartvig J, Sørensen PS, Sellebjerg F. Identification of microRNA changes in the third trimester of pregnancy compared to the post-partum period in multiple sclerosis patients Journal of Neuroimmunology. 275: 110. DOI: 10.1016/J.Jneuroim.2014.08.297 |
0.341 |
|
| 2013 |
Rissanen E, Virta JR, Paavilainen T, Tuisku J, Helin S, Luoto P, Parkkola R, Rinne JO, Airas L. Adenosine A2A receptors in secondary progressive multiple sclerosis: a [(11)C]TMSX brain PET study. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1394-401. PMID 23695433 DOI: 10.1038/Jcbfm.2013.85 |
0.367 |
|
| 2013 |
Tenorio-Laranga J, Peltonen I, Keskitalo S, Duran-Torres G, Natarajan R, Männistö PT, Nurmi A, Vartiainen N, Airas L, Elovaara I, García-Horsman JA. Alteration of prolyl oligopeptidase and activated α-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome. Biochemical Pharmacology. 85: 1783-94. PMID 23643808 DOI: 10.1016/J.Bcp.2013.04.018 |
0.399 |
|
| 2013 |
Jalkanen A, Saraste M, Gfeller A, Surcel HM, Airas L. Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting. Multiple Sclerosis (Houndmills, Basingstoke, England). 19: 1734-42. PMID 23629943 DOI: 10.1177/1352458513485148 |
0.384 |
|
| 2012 |
Airas L, Kaaja R. Pregnancy and multiple sclerosis. Obstetric Medicine. 5: 94-7. PMID 27582863 DOI: 10.1258/Om.2012.110014 |
0.371 |
|
| 2012 |
Paavilainen T, Kurki T, Färkkilä M, Salonen O, Parkkola R, Airas L. Lower brain diffusivity in postpartum period compared to late pregnancy: results from a prospective imaging study of multiple sclerosis patients. Neuroradiology. 54: 823-8. PMID 22160148 DOI: 10.1007/S00234-011-0994-4 |
0.403 |
|
| 2012 |
Rissanen E, Tuisku J, Virta J, Paavilainen T, Parkkola R, Rinne J, Airas L. Increased Microglial Activation in the Brain of Secondary Progressive Multiple Sclerosis Patients Detected Using [11C]PK11195 PET (S21.003) Neurology. 78: S21.003-S21.003. DOI: 10.1212/Wnl.78.1_Meetingabstracts.S21.003 |
0.368 |
|
| 2011 |
de Sa JC, Airas L, Bartholome E, Grigoriadis N, Mattle H, Oreja-Guevara C, O'Riordan J, Sellebjerg F, Stankoff B, Vass K, Walczak A, Wiendl H, Kieseier BC. Symptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice. Therapeutic Advances in Neurological Disorders. 4: 139-68. PMID 21694816 DOI: 10.1177/1756285611403646 |
0.38 |
|
| 2010 |
Rinta S, Airas L, Elovaara I. Is the modulatory effect of pregnancy in multiple sclerosis associated with changes in blood apoptotic molecules? Acta Neurologica Scandinavica. 122: 168-74. PMID 20695850 DOI: 10.1111/J.1600-0404.2009.01301.X |
0.381 |
|
| 2010 |
Airas L, Jalkanen A, Alanen A, Pirttilä T, Marttila RJ. Breast-feeding, postpartum and prepregnancy disease activity in multiple sclerosis. Neurology. 75: 474-6. PMID 20679640 DOI: 10.1212/Wnl.0B013E3181Eb5860 |
0.336 |
|
| 2010 |
Jalkanen A, Alanen A, Airas L. Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland. Multiple Sclerosis (Houndmills, Basingstoke, England). 16: 950-5. PMID 20542921 DOI: 10.1177/1352458510372629 |
0.353 |
|
| 2009 |
Paavilainen T, Kurki T, Korhonen K, Airas L. Apparent Diffusion Coefficient Histograms in the Follow-up of Relapsing-Remitting Multiple Sclerosis. The Neuroradiology Journal. 22: 22-8. PMID 24206949 DOI: 10.1177/197140090902200104 |
0.387 |
|
| 2009 |
Meyer Zu Hörste G, Reiners J, Lehmann HC, Airas L, Kieseier BC. CD73 is expressed on invading T lymphocytes in the inflamed peripheral nerve. Muscle & Nerve. 40: 287-9. PMID 19609917 DOI: 10.1002/Mus.21325 |
0.376 |
|
| 2008 |
Niemelä J, Ifergan I, Yegutkin GG, Jalkanen S, Prat A, Airas L. IFN-beta regulates CD73 and adenosine expression at the blood-brain barrier. European Journal of Immunology. 38: 2718-26. PMID 18825744 DOI: 10.1002/Eji.200838437 |
0.583 |
|
| 2008 |
Mills JH, Thompson LF, Mueller C, Waickman AT, Jalkanen S, Niemela J, Airas L, Bynoe MS. CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis. Proceedings of the National Academy of Sciences of the United States of America. 105: 9325-30. PMID 18591671 DOI: 10.1073/Pnas.0711175105 |
0.552 |
|
| 2007 |
Airas L, Saraste M, Rinta S, Elovaara I, Huang YH, Wiendl H. Immunoregulatory factors in multiple sclerosis patients during and after pregnancy: relevance of natural killer cells. Clinical and Experimental Immunology. 151: 235-43. PMID 18062798 DOI: 10.1111/J.1365-2249.2007.03555.X |
0.471 |
|
| 2007 |
Airas L, Lindsberg PJ, Karjalainen-Lindsberg ML, Mononen I, Kotisaari K, Smith DJ, Jalkanen S. Vascular adhesion protein-1 in human ischaemic stroke. Neuropathology and Applied Neurobiology. 34: 394-402. PMID 18005095 DOI: 10.1111/J.1365-2990.2007.00911.X |
0.457 |
|
| 2007 |
Airas L, Niemelä J, Yegutkin G, Jalkanen S. Mechanism of action of IFN-beta in the treatment of multiple sclerosis: a special reference to CD73 and adenosine. Annals of the New York Academy of Sciences. 1110: 641-8. PMID 17911479 DOI: 10.1196/Annals.1423.067 |
0.604 |
|
| 2007 |
Paavilainen T, Kurki T, Parkkola R, Färkkilä M, Salonen O, Dastidar P, Elovaara I, Airas L. Magnetic resonance imaging of the brain used to detect early post-partum activation of multiple sclerosis. European Journal of Neurology. 14: 1216-21. PMID 17727663 DOI: 10.1111/J.1468-1331.2007.01927.X |
0.375 |
|
| 2007 |
Vallittu AM, Saraste M, Airas L. CCR7 expression on peripheral blood lymphocytes is up-regulated following treatment of multiple sclerosis with interferon-beta. Neurological Research. 29: 763-6. PMID 17711620 DOI: 10.1179/016164107X228633 |
0.41 |
|
| 2007 |
Saraste M, Irjala H, Airas L. Expansion of CD56Bright natural killer cells in the peripheral blood of multiple sclerosis patients treated with interferon-beta. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 28: 121-6. PMID 17603762 DOI: 10.1007/S10072-007-0803-3 |
0.442 |
|
| 2007 |
Saraste M, Väisänen S, Alanen A, Airas L. Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancy. Gender Medicine. 4: 45-55. PMID 17584627 DOI: 10.1016/S1550-8579(07)80008-8 |
0.392 |
|
| 2007 |
Airas L, Nikula T, Huang YH, Lahesmaa R, Wiendl H. Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G. Journal of Neuroimmunology. 187: 205-11. PMID 17561269 DOI: 10.1016/J.Jneuroim.2007.05.008 |
0.417 |
|
| 2006 |
Airas L, Mikkola J, Vainio JM, Elovaara I, Smith DJ. Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis. Journal of Neuroimmunology. 177: 132-5. PMID 16806498 DOI: 10.1016/J.Jneuroim.2006.05.014 |
0.418 |
|
| 2006 |
Saraste M, Ryynänen J, Alanen A, Multanen J, Färkkilä M, Kaaja R, Airas L. Cerebrospinal fluid findings in multiple sclerosis patients before, during and after pregnancy. Journal of Neurology, Neurosurgery, and Psychiatry. 77: 1195-6. PMID 16574729 DOI: 10.1136/Jnnp.2005.085126 |
0.394 |
|
| 2005 |
Airas L, Kurki T, Erjanti H, Marttila RJ. Successful pregnancy of a patient with Balo's concentric sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 11: 346-8. PMID 15957519 DOI: 10.1191/1352458505Ms1158Oa |
0.327 |
|
| 2005 |
Soilu-Hänninen M, Airas L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England). 11: 266-71. PMID 15957505 DOI: 10.1191/1352458505Ms1157Oa |
0.34 |
|
| 2004 |
Niemelä J, Henttinen T, Yegutkin GG, Airas L, Kujari AM, Rajala P, Jalkanen S. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5'-nucleotidase) up-regulation. Journal of Immunology (Baltimore, Md. : 1950). 172: 1646-53. PMID 14734746 DOI: 10.4049/Jimmunol.172.3.1646 |
0.548 |
|
| 2000 |
Airas L, Niemelä J, Jalkanen S. CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism. Journal of Immunology (Baltimore, Md. : 1950). 165: 5411-7. PMID 11067892 DOI: 10.4049/Jimmunol.165.10.5411 |
0.558 |
|
| 1998 |
Airas L. CD73 and adhesion of B-cells to follicular dendritic cells. Leukemia & Lymphoma. 29: 37-47. PMID 9638974 DOI: 10.3109/10428199809058380 |
0.367 |
|
| 1997 |
Arvilommi AM, Salmi M, Airas L, Kalimo K, Jalkanen S. CD73 mediates lymphocyte binding to vascular endothelium in inflamed human skin. European Journal of Immunology. 27: 248-54. PMID 9022026 DOI: 10.1002/Eji.1830270137 |
0.651 |
|
| 1997 |
Airas L, Niemelä J, Salmi M, Puurunen T, Smith DJ, Jalkanen S. Differential regulation and function of CD73, a glycosyl-phosphatidylinositol-linked 70-kD adhesion molecule, on lymphocytes and endothelial cells. The Journal of Cell Biology. 136: 421-31. PMID 9015312 DOI: 10.1083/Jcb.136.2.421 |
0.651 |
|
| 1996 |
Airas L, Jalkanen S. CD73 mediates adhesion of B cells to follicular dendritic cells Blood. 88: 1755-1764. DOI: 10.1182/Blood.V88.5.1755.Bloodjournal8851755 |
0.537 |
|
| 1995 |
Airas L, Hellman J, Salmi M, Bono P, Puurunen T, Smith DJ, Jalkanen S. CD73 is involved in lymphocyte binding to the endothelium: Characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73 Journal of Experimental Medicine. 182: 1603-1608. PMID 7595232 DOI: 10.1084/Jem.182.5.1603 |
0.649 |
|
| Show low-probability matches. |